Literature DB >> 24419619

Crystallization and preliminary X-ray study of Vibrio cholerae uridine phosphorylase in complex with 6-methyluracil.

Igor I Prokofev1, Alexander A Lashkov1, Azat G Gabdulkhakov1, Mariya V Dontsova1, Tatyana A Seregina1, Alexander S Mironov2, Christian Betzel3, Al'bert M Mikhailov1.   

Abstract

Uridine phosphorylase catalyzes the phosphorolysis of ribonucleosides, with the nitrogenous base and ribose 1-phosphate as products. Additionally, it catalyzes the reverse reaction of the synthesis of ribonucleosides from ribose 1-phosphate and a nitrogenous base. However, the enzyme does not catalyze the synthesis of nucleosides when the substrate is a nitrogenous base substituted at the 6-position, such as 6-methyluracil (6-MU). In order to explain this fact, it is essential to investigate the three-dimensional structure of the complex of 6-MU with uridine phosphorylase. 6-MU is a pharmaceutical agent that improves tissue nutrition and enhances cell regeneration by normalization of nucleotide exchange in humans. 6-MU is used for the treatment of diseases of the gastrointestinal tract, including infectious diseases. Here, procedures to obtain the uridine phosphorylase from the pathogenic bacterium Vibrio cholerae (VchUPh), purification of this enzyme, crystallization of the complex of VchUPh with 6-MU, and X-ray data collection and preliminary X-ray analysis of the VchUPh-6-MU complex at atomic resolution are reported.

Entities:  

Keywords:  6-methyluracil; Vibrio cholerae; bacterial uridine phosphorylase

Mesh:

Substances:

Year:  2013        PMID: 24419619      PMCID: PMC3943090          DOI: 10.1107/S2053230X13031877

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  24 in total

1.  [Surgical infected wound treatment in patients with severe gastrointestinal ulcer hemorrhage].

Authors:  V V Ganzhiĭ
Journal:  Klin Khir       Date:  2002 Nov-Dec

2.  [Current methods for local drug therapy of infected wounds].

Authors:  A P Chadaev; A D Klimiashvili
Journal:  Khirurgiia (Mosk)       Date:  2003

3.  Molecular replacement with MOLREP.

Authors:  Alexei Vagin; Alexei Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

4.  The X-ray structure of Salmonella typhimurium uridine nucleoside phosphorylase complexed with 2,2'-anhydrouridine, phosphate and potassium ions at 1.86 A resolution.

Authors:  Alexander A Lashkov; Nadezhda E Zhukhlistova; Azat H Gabdoulkhakov; Alexander A Shtil; Roman G Efremov; Christian Betzel; Al'bert M Mikhailov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

5.  Linking crystallographic model and data quality.

Authors:  P Andrew Karplus; Kay Diederichs
Journal:  Science       Date:  2012-05-25       Impact factor: 47.728

6.  Expression, purification, crystallization and preliminary X-ray structure analysis of Vibrio cholerae uridine phosphorylase in complex with thymidine.

Authors:  Alexander A Lashkov; Azat G Gabdulkhakov; Igor I Prokofev; Tatyana A Seregina; Sergey E Sotnichenko; Andrey V Lyashenko; Alexander A Shtil; Alexander S Mironov; Christian Betzel; Al'bert M Mikhailov
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-10-30

7.  Pyrimidine ribonucleoside phosphorylase activity vs 5- and/or 6-substituted uracil and uridine analogues, including conformational aspects.

Authors:  E Krajewska; D Shugar
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.